atovaquone


Also found in: Medical, Wikipedia.

a·to·va·quone

 (ə-tō′və-kwōn′)
n.
A drug, C22H19ClO3, used to treat pneumonia caused by pneumocystis fungi and, in combination with proguanil, to prevent or treat malaria.

[Perhaps rearrangement of the letters of Aōt(us), night monkey genus on which testing was carried out during the development of atovaquone (Greek a-, without; see a-1 + ous, ōt-,, ear (from the small external ears of night monkeys); see otic) + (par)vaquone, veterinary drug chemically related to atovaquone (parva, specific epithet of Theileria parva, apicomplexan cattle pathogen against which parvaquone is effective, from Latin parva, feminine of parvus, small (from the relatively small size of the pathogen); see pau- in Indo-European roots) + qu(in)one.]
Translations

atovaquone

n atovacuona
Mentioned in ?
References in periodicals archive ?
He was also treated with daily plasmapheresis for 7 days and received atovaquone for pneumocystis prophylaxis.
Eschborn, Germany) and atovaquone from GlaxoSmithKline (Brentford, UK).
In 2000, Krause, who had published concerns of suboptimal results with clindamycin and quinine therapy, reported low side effect and high success with a short course of atovaquone (Mepron) liquid at a dose of 1500 mg/day used in the presence of azithromycin (Zithromax) 500 mg/day.
Primary treatment is Atovaquone and Zithromax given for seven days.
She was continued on her hydroxychloroquine and placed on various supplementary agents, such as atovaquone for pneumocystis jiroveci prophylaxis, calcium and vitamin D as indicated, and deep venous thrombosis as well as gastrointestinal prophylaxis as indicated.
Carola Hunte has succeeded in describing how the antimalarial drug atovaquone binds to its target protein.
Adverse events associated with trimethoprim-sulfamethoxazole and atovaquone during the treatment of AIDSrelated Pneumocystis carinii pneumonia.
falciparum in the lab to atovaquone or ELQ-300 and checked whether the parasite survived over eight weeks.
Glenmark Generics (Europe) Limited (GGEL) announces the first generic launch of Atovaquone Proguanil in the UK following the revocation of the Malarone patent in the High court in the UK.
However, the advent of chloroquine resistance led to the development of other drugs such as mefloquine, sulphadoxine-pyremethamine, artemisinin derivatives and atovaquone proguanil (Malarone) (10).